HDAC6 and idiopathic pulmonary fibrosis: The authors of this study concluded that HDAC6 confers the pronounced hyperproliferative and profibrotic effects to bronchiolar basal cells in IPF, thereby underscoring that inhibition of HDAC6′s deacetylating function plays an important role in the treatment of IPF [174].